Floatz logo

SONALA-001

Progressive Glioblastoma

Mayo ClinicPhase 1/2Active
CCC
53/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
39/ 100
Competitive Position
95/ 100

Competitive context

1 Active assets in the Progressive Glioblastoma cohort.

Asset / SponsorPhaseRating
gi-102
Mayo Clinic
Phase 2CCC

Same molecule, other indications

SONALA-001 is also rated in:

glioblastomaDormant
CCC
Indicative ·
48 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →